Literature DB >> 22923257

Parkinson's disease-like midbrain hyperechogenicity is frequent in amyotrophic lateral sclerosis.

Panteha Fathinia1, Andreas Hermann, Ulrike Reuner, Jan Kassubek, Alexander Storch, Albert C Ludolph.   

Abstract

Clinical and neuroimaging data suggest impairment of the nigrostriatal system in amyotrophic lateral sclerosis (ALS). We thus hypothesized whether Parkinson's disease (PD)-like midbrain sonography findings are also present in ALS. Eighty-six patients with the diagnosis of possible or definite ALS according to revised El Escorial criteria were examined by transcranial B-mode sonography compared to 76 age- and gender-matched controls and 33 PD patients. Hyperechogenic areas of the midbrain representing the substantia nigra were measured planimetrically using standard protocols. In subjects with sufficient temporal acoustic bone windows, mean midbrain hyperechogenic areas were significantly higher in ALS (0.251 ± 0.104 cm(2)) and PD patients (0.286 ± 0.078 cm(2)) compared to controls (0.091 ± 0.054 cm(2)) with no significant difference between ALS and PD patients (one-way ANOVA: F value = 94.3; P < 0.0001). Sixty-seven percent (95 % CI 57-78 %) of ALS patients and 84 % (95 % CI 71-97 %) of PD patients displayed abnormal midbrain hyperechogenic areas (P = 0.383 for group comparison, χ(2) test). No correlations of hyperechogenic area sizes in ALS patients were found in regard to age, gender, ALS subtype (bulbar versus spinal form) or ALS-FRS-R score. In summary, we observed hyperechogenicity of the substantia nigra in patients with sporadic ALS with a frequency similar to that in PD and higher than in all other movement disorders. These findings are important for the diagnosis and differential diagnosis of PD and ALS alike.

Entities:  

Mesh:

Year:  2012        PMID: 22923257     DOI: 10.1007/s00415-012-6654-8

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  12 in total

1.  Targeted antioxidative and neuroprotective properties of the dopamine agonist pramipexole and its nondopaminergic enantiomer SND919CL2x [(+)2-amino-4,5,6,7-tetrahydro-6-Lpropylamino-benzathiazole dihydrochloride].

Authors:  R Danzeisen; B Schwalenstoecker; F Gillardon; E Buerger; V Krzykalla; K Klinder; L Schild; B Hengerer; A C Ludolph; C Dorner-Ciossek; L Kussmaul
Journal:  J Pharmacol Exp Ther       Date:  2005-09-27       Impact factor: 4.030

2.  Dopaminergic deficit in amyotrophic lateral sclerosis assessed with [I-123] IPT single photon emission computed tomography.

Authors:  G D Borasio; R Linke; J Schwarz; V Schlamp; A Abel; P D Mozley; K Tatsch
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-08       Impact factor: 10.154

3.  The combination of dopa-responsive parkinsonian syndrome and motor neuron disease.

Authors:  Elmar Hans Pinkhardt; Anne-Dorte Sperfeld; Hans-Jürgen Gdynia; Albert Christian Ludolph; Jan Kassubek
Journal:  Neurodegener Dis       Date:  2009-03-06       Impact factor: 2.977

4.  Aluminum, calcium, and iron in the spinal cord of patients with sporadic amyotrophic lateral sclerosis using laser microprobe mass spectroscopy: a preliminary study.

Authors:  E J Kasarskis; L Tandon; M A Lovell; W D Ehmann
Journal:  J Neurol Sci       Date:  1995-06       Impact factor: 3.181

5.  Echogenicity of the substantia nigra: association with increased iron content and marker for susceptibility to nigrostriatal injury.

Authors:  Daniela Berg; Wolfgang Roggendorf; Ute Schröder; Rüdiger Klein; Thomas Tatschner; Peter Benz; Oliver Tucha; Michael Preier; Klaus W Lange; Karlheinz Reiners; Manfred Gerlach; Georg Becker
Journal:  Arch Neurol       Date:  2002-06

6.  Extrapyramidal stiffness in patients with amyotrophic lateral sclerosis.

Authors:  Pierre-François Pradat; Gaelle Bruneteau; Elisabetta Munerati; François Salachas; Nadine Le Forestier; Lucette Lacomblez; Timothee Lenglet; Vincent Meininger
Journal:  Mov Disord       Date:  2009-10-30       Impact factor: 10.338

7.  Degeneration of substantia nigra in chronic Parkinson's disease visualized by transcranial color-coded real-time sonography.

Authors:  G Becker; J Seufert; U Bogdahn; H Reichmann; K Reiners
Journal:  Neurology       Date:  1995-01       Impact factor: 9.910

Review 8.  Transcranial sonography in movement disorders.

Authors:  Daniela Berg; Jana Godau; Uwe Walter
Journal:  Lancet Neurol       Date:  2008-11       Impact factor: 44.182

9.  The specificity and sensitivity of transcranial ultrasound in the differential diagnosis of Parkinson's disease: a prospective blinded study.

Authors:  Alexandra Gaenslen; Barbara Unmuth; Jana Godau; Inga Liepelt; Adriana Di Santo; Katherine Johanna Schweitzer; Thomas Gasser; Hans-Jürgen Machulla; Matthias Reimold; Kenneth Marek; Daniela Berg
Journal:  Lancet Neurol       Date:  2008-04-03       Impact factor: 44.182

10.  Diminution of dopaminergic neurons in the substantia nigra of sporadic amyotrophic lateral sclerosis.

Authors:  S Kato; M Oda; H Tanabe
Journal:  Neuropathol Appl Neurobiol       Date:  1993-08       Impact factor: 8.090

View more
  9 in total

Review 1.  [Amyotrophic lateral sclerosis. Multisystem degeneration].

Authors:  A Hübers; A C Ludolph; A Rosenbohm; E H Pinkhardt; J H Weishaupt; J Dorst
Journal:  Nervenarzt       Date:  2016-02       Impact factor: 1.214

2.  Extrapyramidal deficits in ALS: a combined biomechanical and neuroimaging study.

Authors:  Maryse Feron; Annabelle Couillandre; Eya Mseddi; Nicolas Termoz; Malek Abidi; Eric Bardinet; Daniel Delgadillo; Timothée Lenglet; Giorgia Querin; Marie-Laure Welter; Nadine Le Forestier; François Salachas; Gaelle Bruneteau; Maria Del Mar Amador; Rabab Debs; Lucette Lacomblez; Vincent Meininger; Mélanie Pélégrini-Issac; Peter Bede; Pierre-François Pradat; Giovanni de Marco
Journal:  J Neurol       Date:  2018-07-11       Impact factor: 4.849

3.  The diagnostic value of midbrain hyperechogenicity in ALS is limited for discriminating key ALS differential diagnoses.

Authors:  Andreas Hermann; Ulrike Reuner; Jochen Schaefer; Panteha Fathinia; Tordis Leimert; Jan Kassubek; Mario Leimert; Albert C Ludolph; Alexander Storch
Journal:  BMC Neurol       Date:  2015-03-14       Impact factor: 2.474

Review 4.  Diagnostic Accuracy of Transcranial Sonography of the Substantia Nigra in Parkinson's disease: A Systematic Review and Meta-analysis.

Authors:  Dun-Hui Li; Ya-Chao He; Jun Liu; Sheng-Di Chen
Journal:  Sci Rep       Date:  2016-02-16       Impact factor: 4.379

5.  Genetic and constitutional factors are major contributors to substantia nigra hyperechogenicity.

Authors:  Juan F Vázquez-Costa; José I Tembl; Victoria Fornés-Ferrer; Fernando Cardona; Lluis Morales-Caba; Gerardo Fortea; Jordi Pérez-Tur; Teresa Sevilla
Journal:  Sci Rep       Date:  2017-08-02       Impact factor: 4.379

6.  Transcranial sonography changes in heterozygotic carriers of the ATP7B gene.

Authors:  Marta Skowronska; Tomasz Litwin; Iwona Kurkowska-Jastrzębska; Anna Członkowska
Journal:  Neurol Sci       Date:  2020-04-09       Impact factor: 3.307

7.  Role of the nigrosome 1 absence as a biomarker in amyotrophic lateral sclerosis.

Authors:  María Isabel Moreno-Gambín; José I Tembl; Miguel Mazón; Antonio José Cañada-Martínez; Luis Martí-Bonmatí; Teresa Sevilla; Juan F Vázquez-Costa
Journal:  J Neurol       Date:  2021-08-11       Impact factor: 4.849

8.  TARDBP mutations in a cohort of Italian patients with Parkinson's disease and atypical parkinsonisms.

Authors:  Cinzia Tiloca; Stefano Goldwurm; Narghes Calcagno; Federico Verde; Silvia Peverelli; Daniela Calini; Anna Lena Zecchinelli; Davide Sangalli; Antonia Ratti; Gianni Pezzoli; Vincenzo Silani; Nicola Ticozzi
Journal:  Front Aging Neurosci       Date:  2022-09-29       Impact factor: 5.702

9.  Non-Motor Symptoms in Patients Suffering from Motor Neuron Diseases.

Authors:  René Günther; Nicole Richter; Anna Sauerbier; Kallol Ray Chaudhuri; Pablo Martinez-Martin; Alexander Storch; Andreas Hermann
Journal:  Front Neurol       Date:  2016-07-25       Impact factor: 4.003

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.